glp-1 news 2025 november 25 in review: breakthroughs, UPFs under fire, Novonesis advances healthy longevity GLP-1 Drugs: 2025 Pulse Survey

It is possible to be allergic to a protein powder, and some potential allergens need not be disclosed as allergens on labels

Historical Context The path from the discovery of GLP-1 in 1983 to the development of an effective oral non-peptide agonist spans more than four decades of incremental progress

Oral D-methionine protects against cisplatin-induced hearing loss in humans: phase 2 randomized clinical trial in India

Most See Gains, But Your Experience Drives Next Steps Health wins are common, and side effects dont mean stop

Essentially there were three to four extra cases of ischemic optic neuropathy per 10,000 patients in the GLP-1 compared with the other groups